Viome Raises $67 Million in Latest Funding Round to Expand Microbiome and Diagnostic Testing

Seattle-based microbiome startup Viome Life Sciences has raised $67 million in a new funding round, bringing its total funding to over $125 million. The company offers stool, saliva, and blood testing kits for personalized health insights and is developing an FDA-designated diagnostic test for oral and throat cancer.

NNaveen Jain VViome